The National Times - Mercedes-Benz net profit nearly halves amid China, US woes

Mercedes-Benz net profit nearly halves amid China, US woes


Mercedes-Benz net profit nearly halves amid China, US woes
Mercedes-Benz net profit nearly halves amid China, US woes / Photo: © AFP

German carmaker Mercedes-Benz reported Thursday its lowest annual profit since the Covid pandemic, as it counted the cost of US tariffs and cutthroat competition in China.

Change text size:

Net profit for 2025 was 5.3 billion euros ($6.3 billion), Mercedes said, down almost 49 percent from 2024 but better than had been expected in a poll of analysts by financial data firm FactSet.

"Amid a dynamic market environment, our financial results remained within our guidance," chief executive Ola Kaellenius said, adding that he saw hope in over 40 new model launches planned for the next three years.

"We are moving forward with a clear game plan and a very competitive product portfolio," he said.

The firm expects a similarly difficult 2026, however, with revenue projected to be around last year's level of 132.2 billion euros.

Its core profit should be "significantly above" the 2025 figure thanks to an absence of one-off restructuring charges.

But at its core car business, Mercedes sees a profit margin this year of three to five percent -- potentially weaker than the five percent it achieved last year.

Mercedes-Benz shares opened down 4.5 percent in Frankfurt but later recovered a bit, trading down 2.6 percent at midday, making it one of the worst performers in Germany's blue-chip DAX index.

- 'Once-in-a-hundred years transformation' -

A storied company that traces its history back to Carl Benz inventing the first motor car in 1885, Mercedes last year took a hit from US President Donald Trump putting tariffs on foreign carmakers.

Speaking on the earnings call, chief financial officer Harald Wilhelm said the duties introduced partway through last year had cost the company about 1 billion euros.

"It's really a lot of money," he said. "It's going to go up in 2026 because we'll have a full-year impact -- It's going to be a significant number."

The duties came as the company was facing a triple whammy of cratering sales in China, stagnant demand in Europe and the costs of investing into electric cars despite patchy demand.

"The auto industry and our company, we're in a once-in-a-hundred years transformation," Kaellenius said on the call.

"It's happening in an environment that is more dynamic than we have experienced in many, many years."

China, the world's biggest car market, has become a battleground for German carmakers amid a brutal price war and fierce competition from local players like BYD and Geely.

Mercedes-Benz's sales by volume in China plunged 19 percent last year to their lowest level since 2016, helping drag overall worldwide sales down by 10 percent.

Wilhelm said that Mercedes-Benz expected to lose further sales in China despite new launches, and that difficulties in the market could further weigh on results.

"China is always, I think, unforeseeable in terms of the intensity of the competitive environment," he said. "It could be an element which could bring us even further down."

S.Cooper--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: